Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBioquell Regulatory News (BQE)

  • There is currently no data for BQE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re Contract

27 Jun 2011 07:00

RNS Number : 1079J
Bioquell PLC
27 June 2011
 



 

 

27 June, 2011

 

 

BIOQUELL PLC

Completion of the registration of Bioquell China

Award of c. US$ 1 million contract for specialist bio-decontamination equipment to be used by the Chinese Ministry of Agriculture

 

Bioquell PLC (LSE: BQE) ("Bioquell") - provider of specialist low temperature, residue-free bio-decontamination technologies to the healthcare, life sciences and defence sectors - announces that the Chinese authorities have completed the approvals necessary for the registration of Bioquell China.

In addition, Bioquell announces that it has been awarded a contract to supply specialist hydrogen peroxide vapour bio-decontamination equipment to research organisations within the Chinese Government's Ministry of Agriculture worth approximately US$1 million. This bio-decontamination equipment is scheduled to be shipped in the second half of the year - and will be installed and serviced by Bioquell China.

 

Commenting on this contract award in China, Nick Adams, Group Chief Executive of Bioquell PLC, said:

"We are delighted to have won a significant first contract for our unique hydrogen peroxide vapour bio-decontamination equipment from Chinese government research organisations."

"This contract award helps demonstrate the benefits of our substantial investment in the Asia Pacific region - and specifically the establishment of Bioquell China."

 

- Ends -

 

 

Enquiries:

 

Bioquell PLC 01264 835 900

Nick Adams Group Chief Executive

Mark Bodeker Chief Operating Officer / Finance Director

 

Notes to editors:

§ Bioquell is a UK-headquartered, international technology company with two divisions:

o Bio-decontamination which sells specialist bio-decontamination products and services into the Healthcare, Life Sciences and Defence sectors, with most of its revenues generated from overseas customers; and

o TRaC which provides UK corporates with specialist Testing, Regulatory and Compliance services - many of which are required by national and international regulations.

§ Bioquell's gas phase bio-decontamination technology uses hydrogen peroxide vapour - which is highly efficacious at eradicating micro-organisms such as bacteria, viruses and fungi at room temperature - and is subsequently broken down using specialist catalysts to water vapour and oxygen at the end of the bio-decontamination process.

§ Bioquell's bio-decontamination technology:

o is used by bio-pharmaceutical, biologics, biotechnology and research institutions to provide sterile equipment and/or sterile working environments - which is of particular interest to organisations working with biologically-derived drugs;

o is also used by researchers involved in the study of zoonotic transfer whereby diseases in animals can be transferred to humans - with examples including SARS (which is believed to have originated in China) and porcine swine fever (which originated in Mexico)

o is used to eradicate drug resistant organisms associated with Hospital Acquired Infection as well as problematic viruses from the hospital environment. Independent scientific research has demonstrated that 'bioquelling' hospital equipment and facilities reduces the rates of hospital acquired infection;

o was selected by the United States Department of Defense for the JSSED programme to decontaminate sensitive equipment against biological and chemical warfare agents;

o benefits from a number of granted or pending patent filings in the UK and internationally;

o is used in other sectors where bioburden can create significant problems including, for example, the food industry; and

o also comprises specialist filtration technology including peroxide catalysis and chemical, biological, radiological and nuclear ("CBRN") filtration systems used principally in the defence sector.

§ Bioquell currently has overseas operations in the USA, France, Ireland, Singapore and China.

§ TRaC sells its specialist testing services to the product development and engineering departments of a broad range of companies and organisations, principally based in the UK, with a particular focus on the aerospace, military and telecoms sectors.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTSESFILFFSESM
Date   Source Headline
11th Apr 201410:57 amRNSHolding(s) in Company
8th Apr 20147:00 amRNSAnnual Financial Report
2nd Apr 201411:26 amRNSDirector/PDMR Shareholding
28th Mar 201412:38 pmRNSDirector/PDMR Shareholding
18th Mar 20147:00 amRNSAnnual Financial Report
21st Jan 20147:00 amRNSAppointment of Director
17th Jan 20147:00 amRNSPre-close Update
13th Dec 20137:00 amRNSDirector/PDMR Shareholding
12th Dec 20138:25 amRNSDirector/PDMR Shareholding
15th Nov 20137:00 amRNSInterim Management Statement
6th Nov 20132:36 pmRNSBlocklisting Interim Review
23rd Oct 20134:55 pmRNSHolding(s) in Company
26th Sep 20137:00 amRNSDirectorate Change
28th Aug 20137:00 amRNSHalf Yearly Report
13th Aug 20134:23 pmRNSHolding(s) in Company
8th Aug 20134:49 pmRNSNew Directorship of Non-Executive Director
26th Jun 20135:11 pmRNSHolding(s) in Company
26th Jun 201310:53 amRNSHolding(s) in Company
25th Jun 20132:40 pmRNSHolding(s) in Company
24th Jun 20133:04 pmRNSHolding(s) in Company
24th Jun 201311:21 amRNSHolding(s) in Company
13th May 20135:41 pmRNSResult of AGM
13th May 20137:00 amRNSInterim Management Statement
8th May 20139:44 amRNSBlocklisting Interim Review
25th Apr 20138:50 amRNSDirector/PDMR Shareholding
11th Apr 20138:22 amRNSAnnual Financial Report
19th Mar 20137:00 amRNSAnnual Financial Report
21st Jan 20132:29 pmRNSHolding(s) in Company
14th Jan 20137:00 amRNSPre-close update
18th Dec 20127:00 amRNSNew Director
16th Nov 20127:00 amRNSInterim Management Statement
1st Nov 201212:16 pmRNSNew directorship of non-executive director
29th Aug 20127:00 amRNSHalf Yearly Report
9th Jul 201211:25 amRNSHolding(s) in Company
6th Jul 201212:57 pmRNSHolding(s) in Company
5th Jul 201212:16 pmRNSHolding(s) in Company
5th Jul 201210:49 amRNSHolding(s) in Company
2nd Jul 20123:15 pmRNSHolding(s) in Company
24th May 201212:55 pmRNSHolding(s) in Company
24th May 201212:52 pmRNSHolding(s) in Company
21st May 20122:30 pmRNSHolding(s) in Company
15th May 20127:00 amRNSInterim Management Statement
14th May 20122:47 pmRNSResult of AGM
11th May 201211:57 amRNSHolding(s) in Company
11th May 20129:34 amRNSHolding(s) in Company
10th May 201212:19 pmRNSHolding(s) in Company
12th Apr 20128:24 amRNSAnnual Financial Report
29th Mar 201211:23 amRNSDirector/PDMR Shareholding
23rd Mar 201210:04 amRNSHolding(s) in Company
20th Mar 20127:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.